|
1
|
Antequera F, Boyes J and Bird A: High
levels of de novo methylation and altered chromatin structure at
CpG islands in cell lines. Cell. 62:503–514. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okano M, Xie S and Li E: Cloning and
characterization of a family of novel mammalian DNA (cytosine-5)
methyltransferases. Nat Genet. 19:219–220. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones PL, Veenstra GJ, Wade PA, Vermaak D,
Kass SU, Landsberger N, Strouboulis J and Wolffe AP: Methylated DNA
and MeCP2 recruit histone deacetylase to repress transcription. Nat
Genet. 19:187–191. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nan X, Ng HH, Johnson CA, Laherty CD,
Turner BM, Eisenman RN and Bird A: Transcriptional repression by
the methyl-CpG-binding protein MeCP2 involves a histone deacetylase
complex. Nature. 393:386–389. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Ploeg LH and Flavell RA: DNA
methylation in the human gamma delta beta-globin locus in erythroid
and nonerythroid tissues. Cell. 19:947–958. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lichtenstein M, Keini G, Cedar H and
Bergman Y: B cell-specific demethylation: A novel role for the
intronic κ chain enhancer sequence. Cell. 76:913–923. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lübbert M, Miller CW and Koef fler HP:
Changes of DNA methylation and chromatin structure in the human
myeloperoxidase gene during myeloid differentiation. Blood.
78:345–356. 1991.PubMed/NCBI
|
|
9
|
Felgner J, Kreipe H, Heidorn K, Jaquet K,
Heuss R, Zschunke F, Radzun HJ and Parwaresch MR: Lineage-specific
methylation of the c-fms gene in blood cells and macrophages.
Leukemia. 6:420–425. 1992.PubMed/NCBI
|
|
10
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: A fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar
|
|
11
|
Toyooka S, Carbone M, Toyooka KO,
Bocchetta M, Shivapurkar N, Minna JD and Gazdar AF: Progressive
aberrant methylation of the RASSF1A gene in simian virus 40
infected human mesothelial cells. Oncogene. 21:4340–4344. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai CN, Tsai CL, Tse KP, Chang HY and
Chang YS: The Epstein- Barr virus oncogene product, latent membrane
protein 1, induces the downregulation of E-cadherin gene expression
via activation of DNA methyltransferases. Proc Natl Acad Sci USA.
99:10084–10089. 2002. View Article : Google Scholar
|
|
13
|
Mathews LS: Activin receptors and cellular
signaling by the receptor serine kinase family. Endocr Rev.
15:310–325. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mather JP, Moore A and Li RH: Activins,
inhibins, and follistatins: Further thoughts on a growing family of
regulators. Proc Soc Exp Biol Med. 215:209–222. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Risbridger GP, Schmitt JF and Robertson
DM: Activins and inhibins in endocrine and other tumors. Endocr
Rev. 22:836–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matzuk MM, Finegold MJ, Su JG, Hsueh AJ
and Bradley A: α-inhibin is a tumour-suppressor gene with gonadal
specificity in mice. Nature. 360:313–319. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matzuk MM and Bradley A: Identification
and analysis of tumor suppressor genes using transgenic mouse
models. Semin Cancer Biol. 5:37–45. 1994.PubMed/NCBI
|
|
18
|
Schmitt JF, Millar DS, Pedersen JS, Clark
SL, Venter DJ, Frydenberg M, Molloy PL and Risbridger GP:
Hypermethylation of the inhibin α-subunit gene in prostate
carcinoma. Mol Endocrinol. 16:213–220. 2002.PubMed/NCBI
|
|
19
|
Kim YI, Shim J, Kim BH, Lee SJ, Lee HK,
Cho C and Cho BN: Transcriptional silencing of the inhibin-α gene
in human gastric carcinoma cells. Int J Oncol. 41:690–700.
2012.PubMed/NCBI
|
|
20
|
Balanathan P, Ball EM, Wang H, Harris SE,
Shelling AN and Risbridger GP: Epigenetic regulation of inhibin
α-subunit gene in prostate cancer cell lines. J Mol Endocrinol.
32:55–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chatterton Z, Burke D, Emslie KR, Craig
JM, Ng J, Ashley DM, Mechinaud F, Saffery R and Wong NC: Validation
of DNA methylation biomarkers for diagnosis of acute lymphoblastic
leukemia. Clin Chem. 60:995–1003. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu P, Shen JK, Xu J, Trahan CA, Hornicek
FJ and Duan Z: Aberrant DNA methylations in chondrosarcoma.
Epigenomics. 8:1519–1525. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clark SJ, Harrison J, Paul CL and Frommer
M: High sensitivity mapping of methylated cytosines. Nucleic Acids
Res. 22:2990–2997. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sundblad V, Chiauzzi VA, Andreone L, Campo
S, Charreau EH and Dain L: Controversial role of inhibin α-subunit
gene in the aetiology of premature ovarian failure. Hum Reprod.
21:1154–1160. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuchler RJ: Development of animal cell
populations in vitro. Biochemical Methods in Cell Culture and
Virology. Kuchler RJ: Dowden, Hutchinson and Ross Inc. Press;
Stroudsburg, PA: pp. 90–113. 1977
|
|
26
|
Wei QX, Claus R, Hielscher T, Mertens D,
Raval A, Oakes CC, Tanner SM, de la Chapelle A, Byrd JC,
Stilgenbauer S, et al: Germline allele-specific expression of DAPK1
in chronic lymphocytic leukemia. PLoS One. 8:e552612013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alers JC, Rochat J, Krijtenburg PJ, Hop
WC, Kranse R, Rosenberg C, Tanke HJ, Schröder FH and van Dekken H:
Identification of genetic markers for prostatic cancer progression.
Lab Invest. 80:931–942. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suarez BK, Lin J, Burmester JK, Broman KW,
Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC and Catalona
WJ: A genome screen of multiplex sibships with prostate cancer. Am
J Hum Genet. 66:933–944. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Longui CA, Lemos-Marini SH, Figueiredo B,
Mendonca BB, Castro M, Liberatore R Jr, Watanabe C, Lancellotti CL,
Rocha MN, Melo MB, et al: Inhibin α-subunit (INHA) gene and locus
changes in paediatric adrenocortical tumours from TP53 R337H
mutation heterozygote carriers. J Med Genet. 41:354–359. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao J, Richter J, Wagner U, Roth B,
Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ,
et al: Chromosomal imbalances in noninvasive papillary bladder
neoplasms (pTa). Cancer Res. 59:4658–4661. 1999.PubMed/NCBI
|
|
31
|
Ransom DT, Barnett TC, Bot J, de Boer B,
Metcalf C, Davidson JA and Turbett GR: Loss of heterozygosity on
chromosome 2q: Possibly a poor prognostic factor in head and neck
cancer. Head Neck. 20:404–410. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arai M, Yokosuka O, Hirasawa Y, Fukai K,
Chiba T, Imazeki F, Kanda T, Yatomi M, Takiguchi Y, Seki N, et al:
Sequential gene expression changes in cancer cell lines after
treatment with the demethylation agent 5-Aza-2′-deoxycytidine.
Cancer. 106:2514–2525. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sayar N, Karahan G, Konu O, Bozkurt B,
Bozdogan O and Yulug IG: Transgelin gene is frequently
downregulated by promoter DNA hypermethylation in breast cancer.
Clin Epigenetics. 7:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mikata R, Yokosuka O, Fukai K, Imazeki F,
Arai M, Tada M, Kurihara T, Zhang K, Kanda T and Saisho H: Analysis
of genes upregulated by the demethylating agent
5-aza-2′-deoxycytidine in gastric cancer cell lines. Int J Cancer.
119:1616–1622. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bender CM, Pao MM and Jones PA: Inhibition
of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth
of human tumor cell lines. Cancer Res. 58:95–101. 1998.PubMed/NCBI
|
|
36
|
Song SH, Jong HS, Choi HH, Inoue H, Tanabe
T, Kim NK and Bang YJ: Transcriptional silencing of
Cyclooxygenase-2 by hyper-methylation of the 5′ CpG island in human
gastric carcinoma cells. Cancer Res. 61:4628–4635. 2001.PubMed/NCBI
|
|
37
|
Valdez BC, Li Y, Murray D, Corn P,
Champlin RE and Andersson BS: 5-Aza-2′-deoxycytidine sensitizes
busulfan- resistant myeloid leukemia cells by regulating expression
of genes involved in cell cycle checkpoint and apoptosis. Leuk Res.
34:364–372. 2010. View Article : Google Scholar
|
